See more : Isracann Biosciences Inc. (IPOT.CN) Income Statement Analysis – Financial Results
Complete financial analysis of International General Insurance Holdings Ltd. (IGIC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of International General Insurance Holdings Ltd., a leading company in the Insurance – Diversified industry within the Financial Services sector.
- CT Property Trust Limited (BREI.L) Income Statement Analysis – Financial Results
- Seven Principles AG (T3T1.DE) Income Statement Analysis – Financial Results
- Bankinvest – Danske Aktier Akk. KL (BAIDKAAKA.CO) Income Statement Analysis – Financial Results
- ZF Commercial Vehicle Control Systems India Limited (ZFCVINDIA.BO) Income Statement Analysis – Financial Results
- Miwon Commercial Co., Ltd. (002840.KS) Income Statement Analysis – Financial Results
International General Insurance Holdings Ltd. (IGIC)
About International General Insurance Holdings Ltd.
International General Insurance Holdings Ltd. provides specialty insurance and reinsurance solutions worldwide. The company operates through three segments: Specialty Long-tail, Specialty Short-tail, and Reinsurance. It underwrites a diversified portfolio of specialty risks, including energy, property, construction and engineering, ports and terminals, general aviation, political violence, casualty, financial institutions, marine, contingency, and treaty reinsurance. The company was founded in 2001 and is based in Amman, Jordan.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
---|---|---|---|---|---|---|---|---|---|
Revenue | 471.96M | 386.60M | 357.10M | 296.00M | 249.94M | 207.99M | 179.48M | 184.68M | 168.20M |
Cost of Revenue | 360.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 471.60M | 386.60M | 357.10M | 296.00M | 249.94M | 207.99M | 179.48M | 184.68M | 168.20M |
Gross Profit Ratio | 99.92% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 78.93M | 67.50M | 58.90M | 50.30M | 39.22M | 30.84M | 26.75M | 30.87M | 28.30M |
Selling & Marketing | 0.00 | 2.98M | 1.36M | 1.35M | 3.34M | 3.49M | 3.00M | 1.28M | 0.00 |
SG&A | 78.93M | 67.50M | 58.90M | 50.30M | 42.56M | 34.33M | 29.75M | 32.15M | 28.30M |
Other Expenses | 398.16M | -370.07M | -372.51M | -313.16M | -268.89M | -216.87M | -202.34M | 0.00 | 0.00 |
Operating Expenses | 477.08M | -302.57M | -313.61M | -262.86M | -226.32M | -182.54M | -172.59M | 152.66M | 132.40M |
Cost & Expenses | 477.08M | 298.90M | 311.60M | 262.30M | 224.69M | 182.39M | 172.46M | 152.66M | 132.40M |
Interest Income | 40.74M | 21.10M | 14.83M | 12.86M | 11.98M | 10.74M | 10.12M | 0.00 | 0.00 |
Interest Expense | 0.00 | 132.00K | 358.00K | 203.00K | 108.43K | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 2.55M | 3.08M | 3.56M | 2.61M | 1.96M | 1.36M | 1.49M | -30.75M | -37.70M |
EBITDA | 0.00 | 90.94M | 47.06M | 30.01M | 25.58M | 26.81M | 8.37M | 3.13M | -1.90M |
EBITDA Ratio | 0.00% | 22.68% | 13.18% | 12.08% | 10.23% | 12.89% | 4.66% | 1.70% | -1.13% |
Operating Income | 123.01M | 84.03M | 43.49M | 33.14M | 23.62M | 25.45M | 6.89M | 30.75M | 37.70M |
Operating Income Ratio | 26.06% | 21.74% | 12.18% | 11.20% | 9.45% | 12.24% | 3.84% | 16.65% | 22.41% |
Total Other Income/Expenses | 3.04M | -235.18M | 46.67M | 31.45M | 48.03M | 49.21M | -137.85M | 1.27M | -1.90M |
Income Before Tax | 126.05M | 87.70M | 45.50M | 33.70M | 25.25M | 25.60M | 7.02M | 32.02M | 35.80M |
Income Before Tax Ratio | 26.71% | 22.68% | 12.74% | 11.39% | 10.10% | 12.31% | 3.91% | 17.34% | 21.28% |
Income Tax Expense | 7.85M | 2.20M | 1.90M | 2.10M | 1.69M | 62.00K | -14.42K | 932.13K | 800.00K |
Net Income | 118.19M | 89.23M | 46.81M | 27.25M | 23.57M | 25.54M | 7.03M | 32.95M | 35.00M |
Net Income Ratio | 25.04% | 23.08% | 13.11% | 9.21% | 9.43% | 12.28% | 3.92% | 17.84% | 20.81% |
EPS | 2.58 | 1.74 | 0.89 | 0.59 | 0.09 | 0.53 | 0.15 | 0.23 | 0.24 |
EPS Diluted | 2.55 | 1.74 | 0.89 | 0.59 | 0.09 | 0.53 | 0.15 | 0.23 | 0.24 |
Weighted Avg Shares Out | 42.94M | 45.55M | 45.47M | 43.05M | 21.49M | 48.45M | 48.45M | 143.38M | 143.38M |
Weighted Avg Shares Out (Dil) | 43.47M | 45.55M | 45.47M | 43.05M | 21.49M | 48.45M | 48.45M | 143.38M | 143.38M |
Sixfold Fortunes: 3 Bargain Stocks Set for 6X Gains by 2030
3 Must-Buy Stocks Under $15 for a Quick Triple by 2026
IGI Announces Increase in Quarterly Ordinary Common Share Dividend
International General Insurance Holdings Ltd. (IGIC) Q1 2024 Earnings Call Transcript
IGI Establishes a Presence in Lloyd's, Begins Trading May 9, 2024
IGI Reports First Quarter 2024 Unaudited Financial Results
IGI to Release First Quarter 2024 Financial Results on May 7, 2024
IGI Announces that it has Filed its Full Year 2023 Annual Report on Form 20-F, including Audited Financial Statements, with the SEC
International General Insurance Holdings Ltd. (IGIC) Q4 2023 Earnings Call Transcript
IGI Declares Extraordinary Cash Dividend and Regular Ordinary Common Share Dividend
Source: https://incomestatements.info
Category: Stock Reports